Related Experiment Videos
Inhibition of specific effector T cell-target cell conjugates by cell plasma membranes
Journal of Immunology (Baltimore, Md. : 1950)
|March 1, 1978
Abstract:
Conjugate formation between effector T cells raised in vivo in a BALB/c hose had fluorescein diacetate-labeled allogeneic EL4 tumor target cells was observed and scored by using a fluorescence mirroscope. This conjugate formation was found to be specifically inhibited by plasma membrane vesicles isolated from the EL4 cells.
Insights
Effector T cells form conjugates with allogeneic tumor cells. Plasma membrane vesicles from these tumor cells specifically inhibit this T cell-tumor conjugate formation, suggesting a key role in immune interaction.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- T cell-mediated immunity is crucial for recognizing and eliminating tumor cells.
- Understanding the initial interactions between T cells and tumor targets is vital for developing effective immunotherapies.
Purpose of the Study:
- To investigate the formation of conjugates between effector T cells and allogeneic tumor target cells.
- To determine if plasma membrane vesicles from tumor cells can modulate this interaction.
Main Methods:
- In vivo generation of effector T cells in BALB/c mice.
- Labeling of allogeneic EL4 tumor cells with fluorescein diacetate.
- Microscopic observation and scoring of T cell-EL4 cell conjugate formation.
- Incubation with isolated EL4 plasma membrane vesicles.
Main Results:
- Conjugate formation between effector T cells and fluorescein diacetate-labeled EL4 tumor cells was successfully observed.
- This specific conjugate formation was significantly inhibited by the addition of plasma membrane vesicles derived from EL4 cells.
Conclusions:
- Effector T cells form conjugates with allogeneic tumor cells.
- Tumor-derived plasma membrane vesicles can specifically inhibit T cell-tumor conjugate formation, indicating a potential mechanism of immune evasion.